XML 34 R28.htm IDEA: XBRL DOCUMENT
v3.25.3

Goodwill and Intangible Assets, Net (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Goodwill and Intangible Assets Net | At September 30, 2025 and December 31, 2024, goodwill and intangible assets, net consisted of the following (in thousands):
|  | September 30, 2025 |  |  | December 31, 2024 |
Goodwill (1) |  | $ | 10,672 |  |  | $ | 10,672 |
Intangible assets: |  |  |  |  |  |
Acquired IPR&D – OPC1 (from the Asterias Merger) (2) |  | $ | 31,700 |  |  | $ | 31,700 |
Acquired IPR&D – VAC (from the Asterias Merger) (2) |  |  | — |  |  |  | 14,840 |
|  |  | 31,700 |  |  |  | 46,540 |
Intangible assets subject to amortization: |  |  |  |  |  |
Acquired patents |  |  | 18,953 |  |  |  | 18,953 |
Acquired royalty contracts (3) |  |  | 650 |  |  |  | 650 |
Accumulated amortization (4) |  |  | (19,603 | ) |  |  | (19,603 | )
|  |  | — |  |  |  | — |
Intangible assets, net |  | $ | 31,700 |  |  | $ | 46,540 |
(1) Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired and liabilities assumed in connection with our acquisition of Asterias Biotherapeutics, Inc. (“Asterias”) in March 2019 (the “Asterias Merger”). The Company conducted a qualitative goodwill assessment for the second quarter of 2025 and took into consideration the impairment of the VAC indefinite-lived intangible asset. After assessing the totality of relevant events and circumstances, there was no impairment to the goodwill carrying value as of June 30, 2025, and to date, the Company has not recognized any goodwill impairment. (2) Asterias had two IPR&D intangible assets that were valued at $46.5 million as part of the purchase price allocation that was performed in connection with the Asterias Merger. The fair value of these assets at the acquisition date consisted of $31.7 million pertaining to the OPC1 program and $14.8 million pertaining to the VAC platform. As of June 30, 2025, the VAC platform was deemed to be abandoned. As the Company has abandoned the VAC platform and its related research and development efforts, and the IPR&D asset has no alternative future use, the Company derecognized the intangible asset and recorded a non-cash pre-tax impairment charge during the quarter ending June 30, 2025 of $14.8 million, within total operating expenses of the condensed consolidated statement of operations. See Note 13 (Commitments and Contingencies) for additional information. (3) Asterias had royalty cash flows under patent families it acquired from Geron Corporation. Such patent families are expected to continue to generate revenue, are not used in the other acquired IPR&D intangible assets, and are considered to be separate intangible assets under ASC Topic 805, Business Combinations. (4) Lineage recognized $22,000 in amortization expense of intangible assets during the three months ended March 31, 2024 and did not recognize any amortization expense in subsequent quarters as the acquired patents and acquired royalty contracts were fully amortized as of March 31, 2024.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration